| Revenue | SEK 0 | — |
| EBITDA | SEK -14K | +44% |
| Net profit | SEK 2K | +823% |
| Total assets | SEK 69K | +23% |
| Equity | SEK 28K | +7% |
| Employees | 0 | — |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | — | — | — |
| EBITDA | −22 | −24 | −14 |
| Depreciation & amort. | — | — | — |
| EBIT | −22 | −24 | −14 |
| Net financials | — | 1 | 1 |
| Profit before tax | 1 | 0 | 2 |
| Tax | −0 | −0 | −0 |
| Net profit | 1 | 0 | 2 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 47 | 56 | 69 |
| Equity | 26 | 26 | 28 |
| Long-term debt | — | — | — |
| Short-term debt | 21 | 30 | 41 |
| Total debt | 21 | 30 | 41 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EC Chief Auditor | Chief Auditor | 2022 | — | — |
EM External Signatory | External Signatory | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Carballos Klinic AB | Company | 100.0% | 100.0% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Eva Carolina Timén | Chief Auditor | 0 companies |
| Eva Malin Lundberg | External Signatory | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Aymé Pino Rodriguez | Deputy Board Member | 0 companies |
| Wendy Lissette Fahlgren | Board of Directors | 0 companies |
| Alejandro Carballo Palma | Board of Directors | 0 companies |